Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Prostate|July 16, 2015
Characterization of autoimmune inflammation induced prostate stem cell expansionHsing-Hui Wang, Liang Wang, Travis J Jerde, et al.
The Prostate|June 10, 2011
An inducible model of abacterial prostatitis induces antigen specific inflammatory and proliferative changes in the murine prostateJessica M Haverkamp, Bridget Charbonneau, Scott A Crist, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
UTX Epigenetically Imposes a Cytolytic Effector Program in Autoreactive Stem-like CD8+ T cell ProgenitorsHo-Chung Chen, Hsing Hui Wang, Lisa A Kohn, et al.
JCI Insight|September 22, 2017
Combination central tolerance and peripheral checkpoint blockade unleashes antimelanoma immunityPearl Bakhru, Meng-Lei Zhu, Hsing-Hui Wang, et al.
Plos One|December 23, 2009
Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markersWendy W Hwang-Verslues, Wen-Hung Kuo, Po-Hao Chang, et al.
Research Square|January 3, 2024
Inflammation Impacts Androgen Receptor Signaling in Basal Prostate Stem Cells Through Interleukin 1 Receptor AntagonistPaula O Cooper, Jiang Yang, Hsing-Hui Wang, et al.
Nature Communications|May 24, 2024
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancerWolfgang Beckabir, Mi Zhou, Jin Seok Lee, et al.
Communications Biology|October 25, 2024
Inflammation impacts androgen receptor signaling in basal prostate stem cells through interleukin 1 receptor antagonistPaula O Cooper, Jiang Yang, Hsing-Hui Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2020
Concurrent Definitive Immunoradiotherapy for Patients with Stage III-IV Head and Neck Cancer and Cisplatin ContraindicationJared Weiss, Siddharth Sheth, Allison M Deal, et al.
Melanoma Research|March 4, 2021
Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical rationale, biology, and clinical activity (NCI9922)Stergios J Moschos, Zeynep Eroglu, Nikhil I Khushalani, et al.
Pageof 2